Department of Nephrology, The Third Affiliated Hospital of Chongqing Medical University (Gener Hospital).
Department of Nephrology, rheumatism and Immunology, Jiulongpo District People's Hospital of Chongqing.
J Hypertens. 2023 Aug 1;41(8):1306-1312. doi: 10.1097/HJH.0000000000003467. Epub 2023 May 19.
Renal diseases caused by primary hypertension (HTN) are often asymptomatic without sensitive markers for early diagnosis and prediction, easily progressing to severe and irreversible renal damage in patients with clinical manifestations. This study explored whether a classifier developed based on 273 urinary peptides (CKD273) could serve as a potential biomarker for early prediction of renal damage in HTN.
Urinary CKD273 level of healthy individuals, HTN + normoalbuminuric and HTN + albuminuria patients were compared, and 22 baseline data including sex, age, renal function, and hypertensive fundus lesions were collected. Patients diagnosed with HTN, albuminuria, and normal renal function were followed up. According to the follow-up results, the cut-off value of CKD273 in predicting hypertensive renal injury was calculated and analyzed in the high-risk and low-risk groups of HTN patients for its performance in detecting early hypertensive renal injury.
Among a sum of 319 participants, average urinary CKD273 level was significantly higher in patients with HTN than in normal individuals. A total of 147 HTN patients with normal albuminuria were followed up for a mean of 3.8 years. Thirty-five patients showed urinary albumin-to-creatinine ratio (uACR) at least 30 mg/g for three consecutive times. The receiver-operating characteristic (ROC) curve showed that the urinary CKD273 cut-off value for evaluating new-onset proteinuria in patients with HTN was 0.097. Based on this cut-off value, 39 and 108 patients were included in the high-risk and low-risk groups, respectively. Specifically, compared with patients in the low-risk group, those in the high-risk group showed significantly longer duration of HTN, higher proportions of hypertensive fundus lesions and at least 30 mg/g uACR, and higher levels of homocysteine (Hcy), cystatin C (CysC), beta-2 microglobulin (β2-MG), and uACR. 76.9% of high-risk patients had significantly higher new-onset proteinuria than the low-risk group. Correlation analysis demonstrated a positive correlation between urinary CKD273 and UACR ( r = 0.494, P = 0.000). The incidence of new-onset albuminuria was significantly higher in the high-risk group than in the low-risk group, as shown by Cox regression analysis. The areas under the curve of CKD273, Hcy, β2-MG, and CysC were 0.925, 0.753, 0.796, and 0.769, respectively.
Urinary CKD273 is a predictor of new-onset proteinuria in patients with HTN, therefore, it can be used for diagnosing patients with early renal injury in patients with HTN, contributing to early prevention and treatment of hypertensive nephropathy.
原发性高血压(HTN)引起的肾脏疾病通常没有敏感的标志物来进行早期诊断和预测,在有临床表现的患者中,这些疾病很容易进展为严重和不可逆转的肾脏损害。本研究探讨了基于 273 种尿肽(CKD273)开发的分类器是否可作为 HTN 患者肾损伤早期预测的潜在生物标志物。
比较健康个体、HTN+正常白蛋白尿和 HTN+白蛋白尿患者的尿 CKD273 水平,并收集 22 项基线数据,包括性别、年龄、肾功能和高血压眼底病变。对诊断为 HTN、白蛋白尿和正常肾功能的患者进行随访。根据随访结果,计算和分析 CKD273 在预测 HTN 患者肾损伤的高危和低危组中的截断值,以评估其检测早期 HTN 肾损伤的性能。
在总共 319 名参与者中,HTN 患者的平均尿 CKD273 水平明显高于正常个体。共有 147 名 HTN 患者伴正常白蛋白尿,平均随访 3.8 年。35 名患者至少连续 3 次 uACR 达到 30mg/g。受试者工作特征(ROC)曲线显示,评估 HTN 患者新发蛋白尿的尿 CKD273 截断值为 0.097。基于该截断值,分别将 39 名和 108 名患者纳入高危和低危组。具体而言,与低危组患者相比,高危组患者的 HTN 持续时间明显更长,高血压眼底病变和至少 30mg/g uACR 的比例更高,同型半胱氨酸(Hcy)、胱抑素 C(CysC)、β2-微球蛋白(β2-MG)和 uACR 水平也更高。高危组患者的新发蛋白尿发生率明显高于低危组。相关性分析显示,尿 CKD273 与 UACR 呈正相关(r=0.494,P=0.000)。Cox 回归分析显示,高危组新发白蛋白尿的发生率明显高于低危组。CKD273、Hcy、β2-MG 和 CysC 的曲线下面积分别为 0.925、0.753、0.796 和 0.769。
尿 CKD273 是 HTN 患者新发蛋白尿的预测因子,因此,它可用于诊断 HTN 患者的早期肾损伤,有助于早期预防和治疗高血压肾病。